OTC Act of 2023
Summary
Orally Taken Contraception Act of 2023 or the OTC Act of 2023 This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 13, 2023
Last action Jul 14, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jul 14, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jul 13, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jul 13, 2023
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mariannette Miller-Meeks
RRepublican
Co
Ashley Hinson
RRepublican
Co
Diana Harshbarger
RRepublican
Co
Jennifer A. Kiggans
RRepublican
Co
Lori Chavez-DeRemer
RRepublican
Co
Maria Elvira Salazar
RRepublican
Co
Marjorie Taylor Greene
RRepublican
Co
Nancy Mace
RRepublican
Co
Nicole Malliotakis
RRepublican
Co
Stephanie I. Bice
RRepublican
Co
Young Kim
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4626
Scope: US
Hi! I can help you understand HR 4626. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline